Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2026-03-31 @ 12:54 PM
Study NCT ID:
NCT01841359
Status:
COMPLETED
Last Update Posted:
2023-06-29
First Post:
2013-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery
Sponsor:
Joslin Diabetes Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Joslin 08-34
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |